1HUBER J, FOIDART JM, WUTTKE W, et al. Efficacy and tolerability of a monophasic oral contraceptive containing ethi- nylestradiol and drospirenone [ J ]. Eur J Contracept Reprod Health Care, 2000, 5(1 ): 25 -34.
2LOCKHART D, KATZ SS, LISBONA R, et al. Oral contracep- tives and liver disease[J]. Can Mes Assoc J, 1981, 124 (8): 993 -999.
4DINGER JC, HEINEMANN LA, KOHL-HABICH D. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contracep- tives based on 142,475 women -years of observation[J]. Con- traception, 2007, 75(5): 344-354.
1Parsey KS, Pong A. An open-label, muhicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen. Contraception, 2000, 61:105- 111.
2Muhn P, Fuhrmann U, Fritzemeier KH, et al. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Ann N Y Acad Sci, 1995,761:311-335.
3Runnenbaum B, Rabe T. Gynakologische Endokrinologie. Berlin: Springer, 1994:413.
4Oelkers WH. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy. Climacteric, 2005,8 suppl 3 : 19-27.
5Burke AE, Blumenthal PD. Successful use of oral contraceptives. Semin Repord Med, 2001,19:313-321.
6Borges LE, Andrade RP, Aldrighi JM, et al. Effect of a combination of ethinylestradiol 30 μg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception. Contraception, 2006,74:446-450.
7Brown C, Ling F, Wan J. A new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptoms. J Reprod Med,2002,47 : 14-22.
8Dell DL. Premenstrual syndrome, premenstrual dysphoric disorder, and premenstrual exacerbation of another disorder. Clin Obstet Gynecol, 2004,47:568-575.
9Oelkers WK. Effects of estrogen and progestogens on the reninaldosterone system and blood pressure. Steroids, 1996,61 : 166- 171.
10Eriksson E, Sundblad C, Lisjo P, et al. Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls. Psychoneuroendocrinology, 1992,17 : 195-204.
